Literature DB >> 9921904

A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene.

R Vervoort1, R Gitzelmann, W Lissens, I Liebaers.   

Abstract

We have previously sequenced the complete coding region and the promoter region of the beta-glucuronidase gene of a patient with mild mucopolysaccharidosis type VII (MPS VII) and identified a nonsense mutation in the gene inherited from her mother. The mutation inherited from her father was not found. Here, we have extended the sequence analysis of the introns to cover all putative lariat branch points and putative intronic enhancers, although no nucleotide changes have been found in these regions. Careful analysis of mRNA structure by reverse transcription/polymerase chain reaction (RT-PCR) and direct sequencing has revealed the inclusion of a new exon derived from an antisense Alu-repeat in intron 8 and the skipping of exon 9 in a large proportion of the mRNA of our patient. A 2-bp deletion creating a strong 5'-splice site has subsequently been identified in the paternal gene of the patient (IVS8+0.6kbdelTC). With a sensitive RT-PCR assay, we demonstrate that both the inclusion of the Alu-cassette and the skipping of exon 9 are minor events in control samples and that mRNA with both alterations is only found in the IVS8+0.6kbdelTC carrier. The increased proportion of exon 9 skipping seems to be related to the premature termination of translation. This is the third report of a human disease mutation that creates a splice site and activates an antisense Alu-cassette; the question rises as to how these apparently strong cryptic exons are generally excluded from coding sequences.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9921904     DOI: 10.1007/pl00008709

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Authors:  L A Metherell; S A Akker; P B Munroe; S J Rose; M Caulfield; M O Savage; S L Chew; A J Clark
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

Review 2.  The birth of new exons: mechanisms and evolutionary consequences.

Authors:  Rotem Sorek
Journal:  RNA       Date:  2007-08-20       Impact factor: 4.942

3.  Alu-Alu Recombination Underlying the First Large Genomic Deletion in GlcNAc-Phosphotransferase Alpha/Beta (GNPTAB) Gene in a MLII Alpha/Beta Patient.

Authors:  Maria Francisca Coutinho; Liliana da Silva Santos; Lúcia Lacerda; Sofia Quental; Flemming Wibrand; Allan M Lund; Klaus B Johansen; Maria João Prata; Sandra Alves
Journal:  JIMD Rep       Date:  2011-10-20

Review 4.  Transcriptome protection by the expanded family of hnRNPs.

Authors:  Urmi Das; Hai Nguyen; Jiuyong Xie
Journal:  RNA Biol       Date:  2019-01-06       Impact factor: 4.652

5.  Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.

Authors:  Shunji Tomatsu; Koji O Orii; Carole Vogler; Jeffrey H Grubb; Elizabeth M Snella; Monica A Gutierrez; Tatiana Dieter; Kazuko Sukegawa; Tadao Orii; Naomi Kondo; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

Review 6.  Present and future of antisense therapy for splicing modulation in inherited metabolic disease.

Authors:  Belen Pérez; Laura Rodríguez-Pascau; Luisa Vilageliu; Daniel Grinberg; Magdalena Ugarte; Lourdes R Desviat
Journal:  J Inherit Metab Dis       Date:  2010-06-25       Impact factor: 4.982

7.  AluGene: a database of Alu elements incorporated within protein-coding genes.

Authors:  Tal Dagan; Rotem Sorek; Eilon Sharon; Gil Ast; Dan Graur
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 8.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

9.  XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Authors:  Sikandar G Khan; Koji Yamanegi; Zhi-Ming Zheng; Jennifer Boyle; Kyoko Imoto; Kyu-Seon Oh; Carl C Baker; Engin Gozukara; Ahmet Metin; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

10.  IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.

Authors:  Manish J Butte; Charles Haines; Francisco A Bonilla; Jennifer Puck
Journal:  Clin Immunol       Date:  2007-09-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.